Binchen Mao: h-index, Total Citations, and Citation Map
Binchen Mao's h-index is 16 (20 i10-index, 1,411+ total citations across 55+ publications) according to Google Scholar as of June 2026. Binchen Mao is affiliated with Crown Bioscience.
Binchen Mao is a researcher affiliated with Crown Bioscience, specializing in Bioinformatics, Protein modeling, NMR. Their work has been cited 1,411 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Binchen Mao's Citation Metrics
Bibliometric impact based on 55 indexed publications.
- H-Index
- 16
- i10-Index
- 20
- Total Citations
- 1,411
- Citing Countries
- 42
As of June 2026.
Binchen Mao has an h-index of 16 and 1,411 total citations across 55 publications, with research cited by institutions in 42 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Binchen Mao's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
De novo design of a fluorescence-activating β-barrel
2018450
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
64 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher advanced automated protein structure determination by establishing blind testing protocols for NMR data and refining accuracy through Rosetta-based methods.
The researcher advanced oncology drug development by establishing rigorous frameworks for mouse clinical trial design, addressing stromal confounders, and quantifying in vivo drug synergy.
The researcher pioneered the de novo design of a fluorescence-activating beta-barrel, establishing a foundational framework for engineering novel fluorescent proteins from scratch.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
